跳至主要内容
临床试验/NCT06250387
NCT06250387尚未招募不适用

Prospective Feasibility Study of Endobronchial Ultrasound Transbronchial Cryobiopsy (EBUS-TBCB 1.1 mm Probe) Among Patients With Mediastinal Lymphadenopathies

Fondation Hôpital Saint-Joseph0 个研究点目标入组 30 人开始时间: 2024年2月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
主要终点
To evaluate the feasibility of EBUS TBCB 1.1 mm probe.

研究概览

简要总结

Mediastinal lymph nodes enlargement with short axis diameter >15 mm is conventionally defined as a mediastinal lymphadenopathy. The causes of mediastinal lymphadenopathy can be malignant or benign, (infectious, inflammatory, and other such as drug toxicity).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient ≥ 18 years of age
  • Mediastinal and/or hilar lymphadenopathies > 20 mm on an injected chest CT scan
  • Suspicion of lymphoproliferative disease, sarcoidosis or tuberculosis
  • Hypermetabolism of mediastinal and/or hilar lymphadenopathies on PET scan (SUV max > 3)
  • No contraindication for general anesthesia
  • French-speaking Patient
  • -Signed informed consent

排除标准

  • Patient not covered by the French social security system
  • Patient with legal protection
  • Pregnant or breastfeeding patient (if applicable)
  • Patient under guardianship or curatorship
  • Patient deprived of liberty

结局指标

主要结局

To evaluate the feasibility of EBUS TBCB 1.1 mm probe.

时间窗: 6 Months

Number of successes of the procedure. A success is defined by the ability to perform a biopsy.

次要结局

  • To estimate the sensitivity of EBUS TBCB probe 1.1 mm in the diagnosis of mediastinal lymphadenopathy.(7 Months)
  • To estimate the specificity of EBUS TBCB probe 1.1 mm in the diagnosis of mediastinal lymphadenopathy.(7 Months)
  • To assess the post-procedure complications rate.(1 Month)
  • To estimate the procedure time.(Day 0)

研究者

申办方类型
Other
责任方
Sponsor

相似试验